Amneal Pharmaceuticals, Inc. (AMRX)

13.02 -0.22 (-1.66%) USD  |  NASDAQ  |  Mar 09, 13:56
More

Amneal Pharmaceuticals CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade